ArticleApoptosis : an international journal on programmed cell death2026
The circTIMP2/miR-106a/TIMP2 tumor-suppressive axis versus tumor-derived exosomal counteraction in gastric cancer.
Article in Apoptosis : an international journal on programmed cell death, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- CircRAD18 promotes glioblastoma proliferation, migration and invasion via the miR‑1231/LUC7L2 axis.International journal of molecular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastric cancer is a multifactorial disease and remains one of the leading causes of cancer-related deaths worldwide. CircRNAs have emerged as critical regulators in various cancers, while exosomes play essential roles in shaping the tumor microenvironment. However, the function of circTIMP2 and its interaction with exosomes are largely unknown. In this study, we evaluated the expression of circTIMP2 and investigated its biological roles in gastric cancer through a series of in vitro and in vivo experiments. The sponge mechanism of circTIMP2 for miR-106a, together with the target TIMP2, was validated using bioinformatics, luciferase, RNA immunoprecipitation, and fluorescence in situ hybridization assays. The involvement of exosomes and the influence on circTIMP2 were further explored. We found that circTIMP2 was significantly downregulated in gastric cancer, whereas miR-106a was upregulated, accompanied by downregulation of TIMP2. Overexpression of circTIMP2 attenuated malignant behaviors of cancer cells and suppressed subcutaneous tumor growth by upregulating its host gene TIMP2, coinciding with reduced miR-106a and inhibition of Wnt/β-catenin signaling pathway. Mechanistically, circTIMP2 acts as a competitive endogenous RNA by sequestering miR-106a to release its target TIMP2, thereby forming a circTIMP2/miR-106a/TIMP2 feedback loop that suppresses gastric cancer through inhibition of Wnt/β-catenin signaling. Importantly, tumor-derived exosomes counteracted the suppressive effects of circTIMP2, promoting orthotopic tumor progression by inhibiting TIMP2 and reactivating Wnt/β-catenin signaling. Our findings unveil a novel circRNA-guided feedback loop in gastric cancer and highlight how exosome-mediated mechanisms counteract this axis, providing new insights into the molecular pathogenesis of gastric cancer and suggesting potential therapeutic targets.
Indexed as
Identifiers
41854883What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.